277 related articles for article (PubMed ID: 20820751)
1. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
Piao L; Marsboom G; Archer SL
J Mol Med (Berl); 2010 Oct; 88(10):1011-20. PubMed ID: 20820751
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.
Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL
J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938
[TBL] [Abstract][Full Text] [Related]
3. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
Ryan JJ; Archer SL
Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
[TBL] [Abstract][Full Text] [Related]
4. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
[TBL] [Abstract][Full Text] [Related]
6. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
[TBL] [Abstract][Full Text] [Related]
7. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
8. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
Archer SL; Fang YH; Ryan JJ; Piao L
Pulm Circ; 2013 Jan; 3(1):144-52. PubMed ID: 23662191
[TBL] [Abstract][Full Text] [Related]
10. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension.
Sutendra G; Dromparis P; Paulin R; Zervopoulos S; Haromy A; Nagendran J; Michelakis ED
J Mol Med (Berl); 2013 Nov; 91(11):1315-27. PubMed ID: 23846254
[TBL] [Abstract][Full Text] [Related]
11. Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.
Rajagopalan V; Zhao M; Reddy S; Fajardo G; Wang X; Dewey S; Gomes AV; Bernstein D
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H551-62. PubMed ID: 23729213
[TBL] [Abstract][Full Text] [Related]
12. Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling.
Zhang R; Jing ZC
Curr Pharm Des; 2016; 22(31):4780-4795. PubMed ID: 27306090
[TBL] [Abstract][Full Text] [Related]
13. Ca
Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F
J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917
[TBL] [Abstract][Full Text] [Related]
14. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
Piao L; Fang YH; Parikh KS; Ryan JJ; D'Souza KM; Theccanat T; Toth PT; Pogoriler J; Paul J; Blaxall BC; Akhter SA; Archer SL
Circulation; 2012 Dec; 126(24):2859-69. PubMed ID: 23124027
[TBL] [Abstract][Full Text] [Related]
15. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
16. Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy.
Hirschhäuser C; Sydykov A; Wolf A; Esfandiary A; Bornbaum J; Kutsche HS; Boengler K; Sommer N; Schreckenberg R; Schlüter KD; Weissmann N; Schermuly R; Schulz R
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302436
[TBL] [Abstract][Full Text] [Related]
17. Effect of p53 activation on experimental right ventricular hypertrophy.
Veeroju S; Mamazhakypov A; Rai N; Kojonazarov B; Nadeau V; Breuils-Bonnet S; Li L; Weissmann N; Rohrbach S; Provencher S; Bonnet S; Seeger W; Schermuly R; Novoyatleva T
PLoS One; 2020; 15(6):e0234872. PubMed ID: 32559203
[TBL] [Abstract][Full Text] [Related]
18. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
[TBL] [Abstract][Full Text] [Related]
20. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response.
Ohira H; deKemp R; Pena E; Davies RA; Stewart DJ; Chandy G; Contreras-Dominguez V; Dennie C; Mc Ardle B; Mc Klein R; Renaud JM; DaSilva JN; Pugliese C; Dunne R; Beanlands R; Mielniczuk LM
Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1424-1431. PubMed ID: 26060207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]